FTC: UnitedHealth, CVS, Cigna abuse middleman role

The practice inflated costs for consumers and insurers on key treatments for cancer, multiple sclerosis, HIV, organ transplants, and other conditions and procedures, the FTC said. The report demonstrates how pharmacy benefit managers influence every aspect of the pharmaceutical supply chain, an FTC official said at a press briefing on the report Tuesday.